Who is sponsoring NCT06879665?

NCT06879665 is sponsored by Vrije Universiteit Brussel.

What drugs are being tested in NCT06879665?

Interventions in NCT06879665: Well-Beans for Caregivers Program.

What condition does NCT06879665 study?

NCT06879665 studies Adult Caregivers of Individuals With TSC, Tuberous Sclerosis Complex (TSC).

Is NCT06879665 still recruiting?

NCT06879665 is currently enrolling by invitation. Last updated 22 September 2025.

Last reviewed 2025-09-22 · How we verify

NCT06879665: TANDem-2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TANDem-2: Closing the Gap to Interventions for TAND

ENROLLING BY INVITATION NA Last updated 22 September 2025

What this trial tests

NA trial testing Well-Beans for Caregivers Program in Adult Caregivers of Individuals With TSC in 30 participants. Enrolling by invitation.

Timeline

15 July 2025

Primary endpoint
31 December 2026

15 July 2027

Quick facts

Lead sponsor	Vrije Universiteit Brussel
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	15 July 2025
Primary completion	31 December 2026
Estimated completion	15 July 2027
Sites	2 locations across United States, Australia

Drugs / interventions tested

Well-Beans for Caregivers Program

Conditions studied

Adult Caregivers of Individuals With TSC — all drugs for Adult Caregivers of Individuals With TSC →
Tuberous Sclerosis Complex (TSC) — all drugs for Tuberous Sclerosis Complex (TSC) →

Sponsor

Vrije Universiteit Brussel — full company profile →

Who can join

18 and older, any sex, with Adult Caregivers of Individuals With TSC or Tuberous Sclerosis Complex (TSC). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this pilot study is to determine the feasibility, acceptability and impact of a brief behavioral intervention - the "Well-Beans for Caregivers" program, for adult caregivers of individuals with tuberous sclerosis complex (TSC) of any age. The main questions of the study are: 1. Can this innovative, ultra-brief caregiver well-being intervention be delivered feasibly to caregivers via an online modality? 2. How do the caregivers experience the program (acceptability)? 3. Does limited efficacy testing suggest the program has an impact on caregiver's well-being?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Closing the Gap to Interventions for Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): Protocol for a Longitudinal Study of TAND Severity, Predictors, and Caregiver Well-Being (TANDem-2).
de Vries PJ, Chambers N, Campbell E, Gutierrez-Lafrentz L, et al · · 2026 · PMID 42085697 · DOI 10.2196/91726

Verify or expand the search:

Other Vrije Universiteit Brussel trials

Trials by the same sponsor.

NCT07460778 — Development of Serious Games for Rehabilitation: a Delphi Study · NA · recruiting
NCT07359521 — Implementation and Evaluation of a Complex Intervention to Reduce Avoidable Transitions Between Nursing Home and Hospita · NA · not yet recruiting
NCT07356336 — Cognitive Model for Behavioral Interventions as a Non-pharmacological Intervention for Behavioral and Psychological Symp · NA · recruiting
NCT07212829 — The Added Value of Transcranial Direct Current Stimulation (tDCS) During Exercise for People With Chronic Widespread Pai · NA · not yet recruiting
NCT07294131 — Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electro · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06879665 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vrije Universiteit Brussel
Last refreshed: 22 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06879665.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing